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SotalolThe goal of the present study was to determine if nitric oxide (NO) acting on the brain of bullfrog (Lithobates
catesbeianus) is involved in arterial pressure and heart rate (HR) control by inﬂuencing sympathetic activity.
We investigated the effect of intracerebroventricular injections of L-NMMA (a nonselective NO synthase inhibi-
tor) on mean arterial blood pressure (MAP), HR and cutaneous vascular conductance (CVC) of pelvic skin after
intravenous injection ofα or β adrenergic blockers, prazosin or sotalol, respectively. Arterial pressurewas direct-
ly measured by a telemetry sensor inserted in the aortic arch of animals. L-NMMA increased MAP, but did not
change HR. This hypertensive response was inhibited by the pre-treatment with prazosin, but accentuated by
sotalol. The effect of L-NMMA on MAP was also inhibited by i.v. injections of the ganglionic blocker, hexametho-
nium. Thus, NO acting on the brain of bullfrog seems to present a hypotensive effect inﬂuencing the sympathetic
activity dependent on α and β adrenergic receptors in the periphery.
© 2013 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
There is evidence that NO acts on the periphery as a vasodilator, not
only in mammals (Rees et al., 1990), but also in amphibians and other
vertebrates (Hoffmann and Romero, 2000; Donald and Broughton,
2005; Skovgaard et al., 2005). In amphibians, NO has been attributed
to participate in physiological processes besides vascular resistance
(Knight and Burnstock, 1996; Rea and Parsons, 2001; Broughton and
Donald, 2002), such as microvascular permeability (Nguyen et al.,
1995; Rumbaut and Huxley, 2002) and water uptake (Rea and
Parsons, 2001; Rea et al., 2002). Much less is known, however, about
the physiological role of encephalic NO in amphibians. We and others
demonstrated previously that NO acting on brain of toads and frogs is
involved in the reduction of preferred body temperature during hypoxia
(Guerra et al., 2008) and the control of breathing (Hedrick et al., 1998;
Gargaglioni and Branco, 2001), respectively. Moreover, nitrergic cells
are reported to be ubiquitously distributed throughout the anuran
brain (Bruning and Mayer, 1996; Huynh and Boyd, 2007), and there
are NO-producing neurons in the hypothalamic regions and brainstem,
including the nucleus tractus solitarius (NTS), of some anuran species
(Bruning and Mayer, 1996; Munoz et al., 1996; Lazar and Losonczy,
1999) besides bullfrogs (Huynh and Boyd, 2007). To date, no studyto Castellane s/n, 14884-900,
uldade de Ciências Agrárias e
esquita Filho, Jaboticabal, SP,
.
cav.unesp.br (K.C. Bícego).
 OA license.has investigated the possible role of brain NO in the cardiovascular con-
trol of amphibians. At least for mammals, a number of studies support
the idea of a role for NO acting on speciﬁc encephalic nuclei, such as
the paraventricular nuclei (Zhang et al., 1997; Zhang and Patel, 1998)
and the NTS (Harada et al., 1993; Tseng et al., 1996), in decreasing sym-
pathetic nerve activity, especially that which involves cardiovascular
control (cf. Krukoff, 1999; Chen et al., 2001; Patel et al., 2001; Guo et
al., 2009).
The sympathetic nervous system of anurans is organized such that
its paravertebral chains extend from the second to the tenth
spinal nerve, and a mixed sympatovagal trunk innervates the three-
chambered heart (Nilsson, 2011). Adrenaline, released from the sym-
pathetic nerves, is the major mediator of chronotropic and inotropic
effects in the heart via activation of β-adrenergic receptors, namely
β2 receptors (Herman and Sandoval, 1983; Herman and Mata,
1985). At least in bullfrogs, β2 receptors account for the majority of
the receptors found in the atria and the ventricle (Herman et al.,
1996). In terms of the peripheral vasculature, there is evidence for
the vasoconstrictor effect of α-adrenergic receptors in anurans
(Kimmel, 1992; Bianchi-da-Silva et al., 2000), which are activated
by adrenaline, released from sympathetic nerves, and circulating nor-
adrenaline (Azuma et al., 1965). In fact, adrenaline, noradrenaline and
phenylephrine were all demonstrated to cause arterial pressure (AP)
increases by activation of α receptors in amphibians (Erlij et al., 1965;
Kirby and Burnstock, 1969; Lillo, 1979; Herman and Sandoval, 1983).
Moreover, both α and β adrenergic receptors are present in the cuta-
neous vessels of frogs and contribute to vasoconstriction and vasodi-
lation, respectively (Herman and Sandoval, 1983; Malvin and Riedel,
1990). It is also known that β receptors are important for water
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No study has addressed the possible inﬂuence of brain NO on periph-
eral adrenergic activity in amphibians.
Based on the considerations above, our aim was to investigate if
brain NO is involved in the control of AP and HR via peripheral adrener-
gic and/or noradrenergic activity. By using a telemetry sensor to mea-
sure AP directly, we investigated the effect of brain NO inhibition,
induced by intracerebroventricular injection of L-NMMA, on the periph-
eral α- and β-adrenergic inﬂuences on AP, HR and skin blood ﬂow in
bullfrogs.
2. Material and methods
2.1. Animals
We used bullfrogs, Lithobates catesbeianus (Shaw, 1802), of both
sexes, weighing 180–350 g. Frogs were obtained from the bullfrog farm
(CAUNESP) at the College of Agricultural and Veterinarian Sciences —
UNESP, São Paulo state, Brazil. In our laboratory at the Department of
Animal Morphology and Physiology (UNESP), all the animals were
maintained at 25 °C in containers, with free access to tap water from an
artesian well and a basking area, for at least two weeks before experi-
mentation. The animalswere fed Tenebriomolitor larvae and/or commer-
cial carnivorous ﬁsh food two to three times per week. The study was
conductedwith the approval of the local Animal Care andUse Committee
(Protocol 008519-10).
2.2. Surgical procedures
The animals were anesthetized by submergence in an aqueous 0.3%
solution of 3-aminobenzoic acid ethyl ester (MS-222, Sigma, St. Louis,
USA) buffered to pH 7.7 with sodium bicarbonate. After loss of the eye
reﬂex, the animals were ﬁxed to a David Kopf stereotaxic apparatus
(Model 900 Small Animal Stereotaxic, Tujunga, CA, USA). The skin cov-
ering the skullwas removedwith the aid of a bone scraper and an open-
ing was made in the skull above the telencephalon using a small drill
(LB100, Beltec, Araraquara, Brazil). A guide cannula, prepared from a
hypodermic needle segment, 14 mm in length and 0.55 mm in outer di-
ameter, was attached to the tower of the stereotaxic apparatus and
lowered into the lateral cerebral ventricle. These coordinates were
adapted from the encephalic atlas of anurans (Donkelaar, 1998). The
displacement of the meniscus in a water manometer conﬁrmed correct
positioning of the cannula within the lateral ventricle. The oriﬁce
around the cannula was ﬁlled with a paste consisting of a mixture of
equal parts of parafﬁn and glycerin. The cannula was attached to the
bonewith stainless steel screws and acrylic cement. A tight-ﬁtting stylet
was kept inside the guide cannula to prevent occlusion and infection.
The experiments were performed seven days after brain surgery.
To measure pulsatile arterial pressure (PAP) and body temperature,
the frogs were instrumented with a telemetry transmitter (TR43P,
Telemetry Research, New Zealand). This telemetry system, originally
developed for rat instrumentation, was adapted for use in anurans as
follows: the animal was positioned in lateral decubitus, and an incision
wasmade in skin andmuscles at the left side of the abdomen to expose
the left aortic arch (Fig. 1). The aortic arch was isolated using surgical
threads to diminish blood ﬂow, and a catheter, connected to the telem-
etry transmitter, was inserted into a tiny holemade in the artery using a
needle (25 × 0.6 mm). The catheter was ﬁxed to the artery wall with
2-octyl cyanoacrylate (Dermabond® Topical Skin Adhesive, Johnson &
Johnson, Brazil) surgical glue to allow uninterrupted blood ﬂow in the
cannulated vessel. A surgical mesh joined the vessel with the catheter
and was ﬁxed to the surrounding tissue with surgical glue to reinforce
thewhole structure. The body of the telemetry transmitter,whichhous-
es the temperature sensor, was carefully placed inside the abdominal
cavity and sutured to the obliquus internus muscle.After the surgery, the frogs were treated with a prophylactic anti-
biotic (enroﬂoxacin, Flotril®; Schering-Plough, 5.0 mg kg−1, s.c.)
and an analgesic (Flunixina Meglumina, Banamine®; Schering-
Plough, 1.0 mg kg−1, s.c.), according to recommended dosages for
amphibians (Gentz, 2007; Smith, 2007). Five days after guide cannu-
la and telemetry transmitter implantations, the animals were again
anesthetized (see protocol above) and a polyethylene cannula
(PE50) was implanted in the femoral vein for the administration of
adrenergic agonists and antagonists. For measurements of regional
skin blood ﬂow (SkBF), a laser Doppler probe (MSP100XP Standard
Surface Probe, ADInstruments®, Sydney, Australia) was sutured to
the pelvic surface skin. After the surgery, the animals were again
treated with antibiotic and analgesic agents (see above).
2.3. Intracerebroventricular (i.c.v.) microinjections
Microinjections were performed via a thin dental needle (Mizzy,
30 Gauge), which was inserted until its tip was 0.4 mm below the
guide cannula. A volume of 1 μL was injected over a period of 45 s
with a 5-μL Hamilton syringe using a microinjection pump (model
310, Stoelting Co., IL, USA). The movement of an air bubble inside
the PE-10 polyethylene tubing connecting the microsyringe to the
dental needle conﬁrmed drug ﬂow. Thirty minutes were allowed to
elapse before the injection needle was removed from the guide can-
nula to avoid reﬂux and interference in PAP recordings.
At the end of each experiment, 1 μL of 2% Evans blue solution was
microinjected into the lateral ventricle. The animals were euthanized
by submergence in an aqueous 0.025% solution of benzocaine hydro-
chloride buffered to pH 7.7 with sodium bicarbonate (AVMA, 2007).
Upon dissection, we observed that the dye had diffused into the
periventricular tissue and spread along the ventricular system.
2.4. Determination of mean arterial blood pressure (MAP), heart rate
(HR) and body temperature (Tb)
Pulsatile AP and Tb from each animal were continuously monitored
during all experimental protocols by telemetry transmission. The sensor
implanted within the animal's abdominal cavity detects, ampliﬁes and
transmits PAP and Tb data to a receiver (Telemetry Research Receiver,
Auckland, New Zealand). This signal is transmitted to a system of data
acquisition and analysis (PowerLab System, ADInstruments®/Chart
Software, version 7.3, Sydney, Australia). The telemetry transmitters
have been calibrated by the manufacturer using a Mensor 6100 series
reference pressure sensor (pressure range from 760 to 1040 mm Hg;
temperature range from 22 to 40 °C). Heart rate was calculated by
counting the peaks of the PAP recording. Mean arterial pressure was
automatically calculated as MAP = 2/3 DP + 1/3 SP (DP = diastolic
pressure; SP = systolic pressure) from the pulsatile arterial pressure
recording in real-time using the cyclic measurements tool from the
Chart Software.
2.5. Measurements of skin blood ﬂow (SkBF) and calculation of cutaneous
vascular conductance (CVC)
Skin BF was continuously monitored in real-time using a laser
Doppler probe (MSP100XP Standard Surface Probe, ADInstruments®,
Sydney, Australia) sutured to the pelvic surface skin. Signals from the
laser Doppler probe were monitored by a blood ﬂow meter (ML191,
ADInstruments®, Sydney, Australia) connected to a computer (PowerLab
System, ADInstruments®/Chart™ Software, Sydney, Australia).
This methodology was based on previous studies in toads (Viborg and
Rosenkilde, 2004; Viborg and Hillyard, 2005; Viborg et al., 2006) and
crocodiles (Seebacher and Franklin, 2007). Theﬂowmeterwas calibrated
in a colloidal solution of suspended latex spheres of standard size and
concentration, according to recommendations in the manufacturer's
manual (MLA191 calibration kit, ADInstruments).
Fig. 1. Surgical procedure for telemetry transmitter implantation in the left aortic arch (LAA). See text for details. In A, B and C are sequential pictures of localization (A), isolation, catheter in-
sertion (B), and catheter ﬁxation to the left aortic arch and tissue surrounding the vessel (C). In B, a and b refer to the transitory interruption of bloodﬂow through the aortic arch by threads, and
the arrow indicates the location of a polypropylene surgical mesh (see text). In D, schematic drawing of a bullfrog, showing the positioning of the transmitter bodywithin the abdominal cavity
and the catheter inserted into the left aortic arch. A, atrium; AA, aortic arch; CA, carotid artery, DA, dorsal aorta; FA, femoral artery; PCA, pulmocutaneous artery; CoA, conus arteriosus; L, lung;
K, kidney; SF, sciatic artery; V, ventricle. Source: Prepared by the author1
1 The illustration was done by the author based on the drawing of Mr. Lazaroff.
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laser Doppler ﬂow, measured in perfusion units (PU) in mV, over a
steady 1 to 2-min interval, and CVC was then calculated as PU/MAP.
2.6. Experimental protocols
Experiments were performed on unanesthetized and unrestrained
frogs previously prepared as described above.
Once all hemodynamic parameters had stabilized following
venous cannulation (approximately 48 h later), a basal recording
was taken for at least 30 min before each animal was submitted ran-
domly to all protocols. After the basal recording, an intravenous (i.v.)
bolus injection of prazosin (α1-adrenergic antagonist; 1.0 mg kg−1;
Sigma-Aldrich, USA), sotalol (β-adrenergic antagonist; 0.5 mg kg−1;
Sigma, USA) or Ringer's solution was combined with an i.c.v. microin-
jection of L-NMMA (a nonselective NOS inhibitor; 500 μg per animal;Tocris, USA) or mCSF (vehicle) 5 min later. Pulsatile AP was recorded
for approximately 20–30 min after i.c.v. injection. The combinations
among i.v. and i.c.v. injections were performed in a randomized se-
quence. Phenylephrine or isoproterenol was used in order to test
the α or β antagonists' blockade efﬁcacy, respectively. All the experi-
mental protocols were completed in about one week and each animal
received a total of six i.c.v. microinjections (one per day). Another
group of frogs was used to verify if i.v. injection of hexamethonium
(25 mg kg−1; Sigma) is able to inhibit the effect of i.c.v. L-NMMA
(total of four i.c.v. microinjections per animal; one per day). Hexame-
thonium is a neuronal acetylcholine receptor antagonist that blocks
preganglionic sites in both sympathetic and parasympathetic nervous
systems. The dose of hexamethonium used in the present study,
based on studies in reptiles (Eme et al., 2011), birds (Crossley and
Altimiras, 2000) and mammals (Cheung, 1990), was effective as a
ganglionic blocker since it was sufﬁcient to inhibit parasympathetic
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(3.0 mg kg−1; Sigma; data not shown).
Doses of L-NMMA, phenylephrine, isoproterenol, sotalol and atropine
were chosen according to previous studies (Herman and Sandoval,
1983; Herman and Mata, 1985; Skals et al., 2005; Guerra et al., 2008;
Taylor et al., 2012) and pilot experiments. We used the maximum dose
of L-NMMA that induced minimum behavioral alterations (see explana-
tion in Discussion). Regarding prazosin, we used a dose (1 mg kg−1)
based on its maximum solubility (1 mg mL−1; Bianco, 1978). A lower
dose of prazosin (0.5 mg kg−1), as well as the 1 mg kg−1 dose, induced
similar inhibitions of thehypertensive effect of phenylephrine; however,
0.5 mg kg−1 of prazosin did not induce a signiﬁcant reduction in the
bradycardic effect of the α1 agonist (data not shown).
The animals were euthanized once the protocols were completed.
The ionic composition of the mCSF in mEq/L [pH = 7.8 at 25 °C
(Branco et al., 1992)] was 56.6 NaCl, 2.7 KCl, 0.9 CaCl2, 0.45 MgSO4,
and 27.0 NaHCO3.2.7. Data analysis and statistics
Changes inmean arterial pressure (ΔMAP), heart rate (ΔHR) and cu-
taneous vascular conductance (Δ%CVC) were determined by comparing
baseline values withmaximal drug effects (Minson et al., 2002; Green et
al., 2006; Seebacher and Franklin, 2007). A T-test was performed to ver-
ify that differences between the ΔMAP, ΔHR and Δ%CVC were signiﬁ-
cantly different from zero (P b 0.05). The assumptions of analysis of
variance of normality of residuals (Cramer-von Mises, P b 0.05) and
the presence of outlierswere also tested. ANOVAwas then used to assess
the inﬂuence of the four drugs overΔMAP,ΔHRandΔ%CVC and to assess
the signiﬁcant differences between agonist (phenylephrine and isopro-
terenol) effects before and after injection of antagonists (prazosin and
sotalol). Differences among mean values were identiﬁed using a post
hoc Tukey's test and considered signiﬁcant for P b 0.05. Statistical anal-
yses were performed using SAS GLM procedure (Littell et al., 2004).3. Results
3.1. Resting hemodynamic values
Table 1 shows SP, DP, MAP and HR at the time of guide cannula and
telemetry transmitter implantations in anesthetized animals, and 1 and
7 days after surgeries. CVC values are presented only at 7 days
post-surgery because the ﬂow transducer was ﬁxed to the animal skin
5 days after brain surgery. Bullfrogs exhibited normal behavior and sta-
bility of cardiovascular variables 7 days after brain surgery and teleme-
try device implantation. Heart rate increased during anesthesia (PS)
and decreased during the ﬁrst day, becoming stable at the beginning
of experiments, 7 days after surgeries (F(2,22) = 11.54; P b 0.001; re-
peated measures ANOVA). There was no signiﬁcant change in MAP in-
duced by surgeries.Table 1
Mean arterial pressure (MAP) and heart rate (HR) of the bullfrog, Lithobates catesbeianus,
at 24 °C, just after (post-surgery: PS), and 1 (D1), and 7 (D7) days after surgery.
SP
(mm Hg)
DP
(mm Hg)
MAP
(mm Hg)
HR
(bpm)
CVC
(mV/mm Hg)
Post-surgery 28.4 ± 1.3 21.5 ± 1.3 25.3 ± 1.2 48.9 ± 1.78 –
Day 1 28.7 ± 1.8 22.4 ± 1.5 25.7 ± 1.6 37.4 ± 2.3a –
Day 7 29.2 ± 1.6 23.3 ± 1.4 26.4 ± 1.5 36.3 ± 2.2a 0.00259 ±
0.00091
N = 12 animals.
a Signiﬁcant difference from PS value.3.2. Effect of brain NO synthase blockade associated with the antagonism of
systemicα- orβ-adrenergic receptors in cardiovascular function of bullfrogs
Fig. 2 shows representative recordings of PAP, MAP and HR after
i.c.v. injection of L-NMMA plus pretreatment with i.v. injection of
Ringer's (Fig. 2A), prazosin (Fig. 2B) or sotalol (Fig. 2C). L-NMMA injec-
tion (Fig. 2A) caused no change in HR but increased MAP, a response
that was inhibited by prazosin (Fig. 2B) but accentuated by sotalol
(Fig. 2C).
Fig. 3 shows that i.c.v. injections of L-NMMA caused signiﬁcant
increase in MAP (F(3,43) = 40.17; P b 0.0001; Tukey's test) and de-
crease in CVC in the seat patch skin of bullfrogs (effect of treatment:
F(3,26) = 11.15; P b 0.0001; Tukey's test), but did not change HR
compared with i.c.v. injection of mCSF. Intravenous injection of
prazosin alone caused no signiﬁcant decrease in MAP or an increase
in CVC, but signiﬁcantly inhibited L-NMMA-induced hypertension
(F(3,43) = 40.17; P b 0.0001; Tukey's test; Fig. 3). Neither prazosin
nor L-NMMA affected HR. Prazosin inhibited both the hypertensive
(F(2,31) = 42.47; P b 0.0001) and the bradycardic (F(2,31) = 34.38;
P b 0.0001) effects of the α1-adrenergic agonist, phenylephrine
(100 μg kg−1) (Fig. 4). A lower dose of phenylephrine, 50 μg kg−1,
was tested but it increased AP with a small reduction in HR (data
not shown). Phenylephrine signiﬁcantly decreased %CVC in the ven-
tral pelvic skin, which was not inﬂuenced by prazosin (Fig. 4).
Fig. 5 shows that theβ-adrenergic antagonist, sotalol, used in tandem
withmCSF (i.c.v.), did not changeMAP,HR and%CVC, but signiﬁcantly in-
creased the pressor response of L-NMMA (F(3,44) = 43.89; P b 0.0001;
Tukey's test) without affecting the effect of L-NMMA on %CVC. No treat-
ment affected HR. The effectiveness of sotalol as a β antagonist was con-
ﬁrmed as it completely blocked the tachycardic effect of the β agonist,
isoproterenol (F(2,34) = 89.42; P b 0.0001; Fig. 6). A higher dose of
sotalol (3 mg kg−1) was also capable of blocking the tachycardic effect
of isoproterenol (data not shown); however, as 3 mg kg−1 of sotalol
alone caused a slight reduction in HR (−19.44 ± 3.4%), the dose of
0.5 mg kg−1 was used in the present study. Intravenous injection of iso-
proterenol increased CVC in the seat patch skin, which was completely
blocked by sotalol (F(2,19) = 7.81; P b 0.05; Fig. 6).
3.3. Effect of brain NO synthase blockade associated with the ganglionic
blockade on cardiovascular function in bullfrogs
In Fig. 7, i.v. injection of the ganglionic blocker, hexamethonium,
combined with i.c.v. microinjection of mCSF, did not change MAP and
HR. However, pretreatment with hexamethonium inhibited the hyper-
tensive effect evoked by L-NMMA (F(3,30) = 31.03; P b 0.0001). None
of the treatments caused signiﬁcant changes in HR.
4. Discussion
To our knowledge, this is the ﬁrst study to demonstrate that brain
NO seems to play a role in MAP control in bullfrogs by affecting sympa-
thetic activity in amanner dependent on vascularα1- and β-adrenergic
receptors.
4.1. Direct measurements of pulsatile arterial pressure by telemetry in
bullfrogs: considerations about the method
As far as we know, this is the ﬁrst time blood pressure was directly
measured in anurans using telemetry. The anatomical differences be-
tween anuran amphibians andmammalsmake further procedural adjust-
ments necessary for the cannulation of blood vessels and arrangement of
the transmitter device inside the body cavity, which does not present a
thoracic cavity limited by ribs and a diaphragm. Cannulation of the dorsal
artery of amphibians (homologous to the mammalian abdominal aorta
(Van Vliet and West, 1994), which is generally used for measuring AP
by telemetry in these animals) has several ramiﬁcations to the kidneys
Fig. 2. Representative recordings of pulsatile arterial pressure (PAP), mean arterial pres-
sure (MAP) and heart rate (HR) of a bullfrog. Effect of intracerebroventricular (i.c.v.) injec-
tion of L-NMMA (500 μg per animal) after intravenous (i.v.) injection of Ringer's solution
(A), 1.0 mg kg−1 of prazosin (B) or 0.5 mg kg−1 of sotalol (C) on PAP, MAP and HR.
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Fig. 3. Changes in mean arterial blood pressure (ΔMAP), heart rate (ΔHR) and cutane-
ous vascular conductance (Δ%CVC) after intracerebroventricular (i.c.v.) injection of
L-NMMA (500 μg per animal) or mock cerebrospinal ﬂuid (mCSF; 1 μL), preceded by
intravenous (i.v.) injection of prazosin (Praz; 1.0 mg kg−1) or Ringer (Ring). CVC is
expressed as % of baseline (%CVC baseline). Data are expressed as means ± s.e.m.
Values indicated by different letters are signiﬁcantly different from each other by
Tukey's test (P b 0.05). Number of the animals is between parentheses.
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to be unfeasible, as we could not isolate it. In anurans, catheterization of
thedorsal aortawould increase the chance of organdamage in this region,
compromising important organs such as the urinary bladder, which is a
physiological reservoir of water in these animals (Shoemaker and Nagy,
1977). Thus, the aortic arch was chosen for catheter insertion, as it was
easily accessible when the surgical incision was performed laterally.
The implantation of a telemetry transmitter for PAP measure-
ments proved to be a valuable method for this kind of long experi-
mental protocol used in the present study, thereby reducing the
number of animals used and avoiding the likely occlusion of the fem-
oral arterial catheter after extended use. This is particularly important
when using amphibians collected from their natural environment.
Thus, monitoring blood pressure for long periods can be a very reli-
able method for assessing the inﬂuence of seasonality, feeding, infec-
tion or even pharmacological manipulations on cardiovascular
function in the same animal, excluding possible inﬂuences from han-
dling and anesthesia.
Comparing the present study with those that used a catheter in
the femoral artery, we can notice that MAP and HR values of our bull-
frogs at 24 °C (Table 1) are within the range previously reported at
temperatures from 20 to 25 °C (Herman and Mata, 1985; Rocha and
Branco, 1998; Bicego-Nahas and Branco, 1999; Taylor et al., 2012).
Fig. 4. Changes in mean arterial blood pressure (ΔMAP), heart rate (ΔHR) and cutane-
ous vascular conductance (Δ%CVC) after intravenous (i.v.) injection of phenylephrine
preceded by Ringer (vehicle) or prazosin. CVC is expressed as % of baseline (%CVC base-
line). Data are expressed as means ± s.e.m. Values indicated by different letters are
signiﬁcantly different from each other by Tukey's test (P b 0.05). Number of the ani-
mals is between parentheses.
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Fig. 5. Effect of intracerebroventricular (i.c.v.) injection of L-NMMA (500 μg per animal) or
mock cerebrospinal ﬂuid (mCSF), preceded by intravenous (i.v.) injection of sotalol
(0.5 mg kg−1) or Ringer (Ring) on mean arterial blood pressure (ΔMAP), heart rate
(ΔHR) and cutaneous vascular conductance (Δ%CVC). CVC is expressed as % of baseline
(Δ%CVC baseline). Data are expressed asmeans ± s.e.m. Values indicated by different let-
ters are signiﬁcantly different from each other by Tukey's test (P b 0.05). Data for “Ring
i.v. + mCSF i.c.v.” and “Ring i.v. + L-NMMA i.c.v.” are the same plotted in Fig. 2. Number
of the animals is between parentheses.
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in bullfrogs
There are many studies reporting increases inMAP, sympathetic ac-
tivity and plasma levels of catecholamines in response to brain NOS in-
hibition in mammals (Matsumura et al., 1998; Shankar et al., 1998).
While a clear hypertensive response is observed following the inhibi-
tion of NO production in the mammalian brain, HR responses remain
unclear as some data indicate tachycardia, while others indicate brady-
cardia, associatedwith NO inhibition (cf. Krukoff, 1999). These different
results seem to be related to the dose of the NOS inhibitor and/or the
site of action in the central nervous system (CNS) (cf. Krukoff, 1999).
NO can modulate preganglionic parasympathetic neurons in the nucle-
us ambiguous and in the dorsal vagal motor nucleus, acting on HR con-
trol (Hornby and Abrahams, 2000; Fletcher et al., 2006; cf. Zanzinger,
1999). The absence of a bradycardic reﬂex response to the pressor effect
caused by L-NMMA in the present study (Fig. 3) may suggest an inﬂu-
ence of NO on baroreﬂex sensitivity in bullfrogs, interfering with the
parasympathetic cardiac limb. There is evidence in mammals of the in-
volvement of NO in the increase (Qadri et al., 1999; Souza et al., 2001;
Carvalho et al., 2006; Fletcher et al., 2006; Souza et al., 2009), as well
as in the decrease (Liu et al., 1996; Murakami et al., 1998), of baroreﬂex
sensitivity.In the present study it is not possible to specify the exact site
where NO acts to affect blood pressure, since i.c.v. injections of
L-NMMA affected a large portion of the brain in frogs (all ventricles
became blue after i.c.v. injection of 1 μL of Evans blue). At least in
mammals, there are several important regions of the CNS related to
cardiovascular regulation by NO, such as: i) the hypothalamus, espe-
cially the paraventricular (PVN) and supraoptic nuclei (Mizukawa et
al., 1989; Yang et al., 1999); ii) the brainstem, where NO-producing
neurons are found in the NTS and several subdivisions of the ventro-
lateral medulla, and iii) the spinal cord, which includes NO-producing
sympathetic preganglionic neurons of intermediolateral cell column
(Chen et al., 2001; cf. Krukoff, 1999). Regarding amphibians, there is
evidence that the NTS is involved in blood pressure control in toads
(Bianchi-da-Silva et al., 2000). Moreover, NO-producing neurons are
found in hypothalamic and brainstem regions, including the NTS
of some anuran species, such as Rana perezi (Munoz et al., 1996),
Xenopus laevis (Bruning and Mayer, 1996; Munoz et al., 1996; Lazar
and Losonczy, 1999), and L. catesbeianus (Huynh and Boyd, 2007).
However, the role of NO at speciﬁc sites controlling MAP in amphib-
ians is a matter of further investigation in our laboratory.
There is evidence to suggest that the reduction of brain perfusion
induces a sympathetic hypertensive response in mammals (Paton et
al., 2009), which could lead us to interpret that the MAP increase is
caused by i.c.v. injection of L-NMMA (~1.5 mg kg−1) in our bullfrogs
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However, in contrast to mammals, the absence of an endothelial NO
system is well documented in anurans, at least in large conductance
blood vessels, such as systemic and pulmonary arteries, and mesen-
teric resistance arteries (Broughton and Donald, 2002; Donald and
Broughton, 2005; Jennings and Donald, 2008, 2010; Trajanovska and
Donald, 2011). Recently, Trajanovska and Donald (2011) showed
that the eNOS gene is expressed in several non-vascular tissues, but
not in the vascular endothelium of the frog, Xenopus tropicalis. The au-
thors concluded that eNOS in adult amphibians has no role as an en-
dothelial regulator of the vasculature. In fact, NO control of systemic
vessel resistance in toads is provided by nitrergic nerves (Broughton
and Donald, 2002; Donald and Broughton, 2005; Jennings and
Donald, 2008, 2010). Furthermore, it was documented that peripheral
injection of 50 mg kg−1 of L-NAME in bullfrogs (Rea et al., 2002) in-
creases skin permeability without any change in vascular resistance
or blood pressure.
Microinjection of L-NMMA into the lateral ventricle of bullfrogs oc-
casionally induced an exploratory behavior in these animals. Behavioral
responses may indirectly cause baseline cardiovascular alterations. In
fact, activation of the grooming reﬂex was also demonstrated to occur
in rats after intra-PVN injection of L-NAME (Cruz and Machado, 2009),which in this case appeared not to be related to the pressor effect of
L-NAME, since Zhang et al. (1997) and Zhang and Patel (1998) showed
that an increase in MAP and HR occurs even in anesthetized animals. In
our frogs, the MAP increase caused by L-NMMA injection was always
observed before behavioral changes, excluding an indirect inﬂuence
on cardiovascular modulation by brain NO.4.3. Role of peripheral α1- and β-adrenergic receptors on i.c.v. L-NMMA-
induced cardiovascular effects in bullfrogs
According to our results, L-NMMA in the CNS of bullfrogs increases
MAP viaα1-adrenoreceptor activation by adrenaline and/or circulating
noradrenaline. This result suggests the existence of an inhibitory tonus
of brain NO on sympathetic activity on the cardiovascular system that is
dependent on α1-adrenoreceptors, corroborating previous studies in
mammals (cf. Krukoff, 1999). The α1-antagonist, prazosin, inhibited
the hypertensive effects of both L-NMMA (Figs. 2B and 3) and phenyl-
ephrine (Fig. 4) in frogs, which conﬁrms the vasoconstrictor action of
α1 receptors in these animals.
In contrast to the results with the α-adrenoceptors, the blockade
of the β-adrenergic receptors with sotalol accentuated the hyperten-
sive effect of L-NMMA in the CNS of bullfrogs. Therefore, in these an-
imals, L-NMMA seems to activate the sympathetic nervous system
(SNS) to release adrenaline/noradrenaline that acts on both α-
(Fig. 3) and β- (Fig. 5) adrenoceptors to cause vasoconstriction and
vasodilation, respectively.
Neither prazosin nor sotalol signiﬁcantly inﬂuenced the reduction in
CVC of ventral pelvic skinmicrovasculature induced by L-NMMA(Figs. 3
and 5), indicating the involvement of α- and β-adrenoceptors of other
vascular beds in these responses. In contrast, sotalol completely blocked
the increased CVC induced by isoproterenol (Fig. 6). This result indi-
cates that β-adrenoreceptors in the microvasculature of ventral pelvic
skinmay be important forwater uptake, not only inmore terrestrial an-
urans, such as the toads, Bufo woodhouseii, Bufo punctatus and Bufo bufo
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bullfrogs (present study), a more aquatic species.
The participation of the SNS in the L-NMMA effect was conﬁrmed by
the ganglionic blockadewith hexamethonium(Fig. 7). However, one can-
not rule out possible humoral inﬂuences, such as the renin–angiotensin
system or the non-mammalian vasopressin analogue, arginine vasotocin
(AVT; Acharjee et al., 2004). At least in mammals, there is evidence that
thepressor effect of i.c.v. L-NAME ismediatedpartly by the SNS, andpartly
by the renin–angiotensin system (Moriguchi et al., 1998). Moreover,
brain NO can inﬂuence MAP by inhibiting vasopressin production,
thereby maintaining the baseline MAP (Liu et al., 1998). In anurans,
the renin–angiotensin system is known to play an important role in
responses to hypotension, which may be related to hemorrhage or
dehydration conditions (West et al., 1998). Regarding AVT, there is
high vasotocinergic ﬁber density (Van Vossel-Daeninck et al., 1981;
Mathieson, 1996) and a dense accumulation of mRNA for AVT receptors
in the CNS, more speciﬁcally in hypothalamic areas (Kohno et al., 2003;
Acharjee et al., 2004; Hasunuma et al., 2007). The association of brain
NOwith renin–angiotensin system and/or AVT remains to be elucidated
in bullfrogs.
In summary, our data indicate that, NO acting on the CNS of bull-
frogs seems to be important for controlling blood pressure via inhibi-
tion, at least in part, of the sympathetic activity dependent on α- and
β-adrenergic receptors in systemic vessels.
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